FBT Company Profile and Key Details

First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT) closed at $261.85 USD, losing -$0.43 (-0.16%) from the previous close of $262.28. The stock is currently within 5% of its 52-week high $173.98 and $274.99. With a market capitalization of about $1.63 billion, First Trust NYSE Arca Biotechnology Index Fund is classified as a small-cap and shows lower-than-market volatility (beta ~0.76). Key stats such as the average daily volume over the past year has been around 73.97 thousand shares, volume is running light vs its 52-week average. Headquartered in Wheaton, IL, First Trust NYSE Arca Biotechnology Index Fund operates in the Financial Services sector and the Asset Management industry. The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Short-term trend indicators are mixed aligned (SMA20 -1.1%, SMA50 -1.92%, SMA200 11.78%). The stock’s 14-day RSI is 43.86 (neutral), while the ATR of 3.55 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -7.43% below its high and over 47.28% above its low. Average 10-day trading volume of 31.67 thousand shares is below the 3-month average of 72.25 thousand, indicating normal recent market interest.

Our AI price prediction model suggests that First Trust NYSE Arca Biotechnology Index Fund stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band.